abstract |
In certain aspects, the present invention provides methods of administering an activin-ActRIIa antagonist to a patient, and methods of managing a patient being treated with an activin-ActRIIa antagonist. In certain aspects, these methods involve measuring one or more hematological parameters in a patient. |